JP6479475B2 - 薬剤投与量情報を決定するための方法及び装置 - Google Patents

薬剤投与量情報を決定するための方法及び装置 Download PDF

Info

Publication number
JP6479475B2
JP6479475B2 JP2014550529A JP2014550529A JP6479475B2 JP 6479475 B2 JP6479475 B2 JP 6479475B2 JP 2014550529 A JP2014550529 A JP 2014550529A JP 2014550529 A JP2014550529 A JP 2014550529A JP 6479475 B2 JP6479475 B2 JP 6479475B2
Authority
JP
Japan
Prior art keywords
analyte
processors
user
data
level
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2014550529A
Other languages
English (en)
Japanese (ja)
Other versions
JP2015505264A5 (OSRAM
JP2015505264A (ja
Inventor
バリー タウブ，マーク
バリー タウブ，マーク
サトリャ ブディマン，アーウィン
サトリャ ブディマン，アーウィン
カラン，ジャイ
クリスチャン ダン，ティモシー
クリスチャン ダン，ティモシー
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Abbott Diabetes Care Inc
Original Assignee
Abbott Diabetes Care Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Diabetes Care Inc filed Critical Abbott Diabetes Care Inc
Publication of JP2015505264A publication Critical patent/JP2015505264A/ja
Publication of JP2015505264A5 publication Critical patent/JP2015505264A5/ja
Application granted granted Critical
Publication of JP6479475B2 publication Critical patent/JP6479475B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/48—Other medical applications
    • A61B5/4836—Diagnosis combined with treatment in closed-loop systems or methods
    • A61B5/4839—Diagnosis combined with treatment in closed-loop systems or methods combined with drug delivery
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue
    • A61B5/14532—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue for measuring glucose, e.g. by tissue impedance measurement
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/72—Signal processing specially adapted for physiological signals or for diagnostic purposes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/72—Signal processing specially adapted for physiological signals or for diagnostic purposes
    • A61B5/7271—Specific aspects of physiological measurement analysis
    • A61B5/7275—Determining trends in physiological measurement data; Predicting development of a medical condition based on physiological measurements, e.g. determining a risk factor
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H20/00—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance
    • G16H20/10—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients
    • G16H20/17—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients delivered via infusion or injection
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H40/00—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices
    • G16H40/60—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices
    • G16H40/63—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices for local operation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue
    • A61B5/14507—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue specially adapted for measuring characteristics of body fluids other than blood
    • A61B5/1451—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue specially adapted for measuring characteristics of body fluids other than blood for interstitial fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue
    • A61B5/1495—Calibrating or testing of in-vivo probes
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
    • G16H50/30—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for calculating health indices; for individual health risk assessment

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medical Informatics (AREA)
  • Biomedical Technology (AREA)
  • Physics & Mathematics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pathology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Molecular Biology (AREA)
  • Surgery (AREA)
  • Biophysics (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Primary Health Care (AREA)
  • Epidemiology (AREA)
  • Psychiatry (AREA)
  • Artificial Intelligence (AREA)
  • Computer Vision & Pattern Recognition (AREA)
  • Physiology (AREA)
  • Signal Processing (AREA)
  • Optics & Photonics (AREA)
  • Emergency Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Business, Economics & Management (AREA)
  • General Business, Economics & Management (AREA)
  • Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)
  • Measuring And Recording Apparatus For Diagnosis (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
JP2014550529A 2011-12-30 2012-12-29 薬剤投与量情報を決定するための方法及び装置 Active JP6479475B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201161582209P 2011-12-30 2011-12-30
US61/582,209 2011-12-30
PCT/US2012/072213 WO2013102158A1 (en) 2011-12-30 2012-12-29 Method and apparatus for determining medication dose information

Publications (3)

Publication Number Publication Date
JP2015505264A JP2015505264A (ja) 2015-02-19
JP2015505264A5 JP2015505264A5 (OSRAM) 2016-02-25
JP6479475B2 true JP6479475B2 (ja) 2019-03-06

Family

ID=48698675

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2014550529A Active JP6479475B2 (ja) 2011-12-30 2012-12-29 薬剤投与量情報を決定するための方法及び装置

Country Status (10)

Country Link
US (2) US20130184547A1 (OSRAM)
EP (3) EP3662965B1 (OSRAM)
JP (1) JP6479475B2 (OSRAM)
AU (5) AU2012362155A1 (OSRAM)
CA (1) CA2840644A1 (OSRAM)
DK (1) DK3662965T3 (OSRAM)
ES (1) ES2992389T3 (OSRAM)
FI (1) FI3662965T3 (OSRAM)
LT (1) LT3662965T (OSRAM)
WO (1) WO2013102158A1 (OSRAM)

Families Citing this family (52)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20190357827A1 (en) 2003-08-01 2019-11-28 Dexcom, Inc. Analyte sensor
US9788771B2 (en) 2006-10-23 2017-10-17 Abbott Diabetes Care Inc. Variable speed sensor insertion devices and methods of use
US7697967B2 (en) 2005-12-28 2010-04-13 Abbott Diabetes Care Inc. Method and apparatus for providing analyte sensor insertion
US11298058B2 (en) 2005-12-28 2022-04-12 Abbott Diabetes Care Inc. Method and apparatus for providing analyte sensor insertion
US8140312B2 (en) 2007-05-14 2012-03-20 Abbott Diabetes Care Inc. Method and system for determining analyte levels
US9675290B2 (en) 2012-10-30 2017-06-13 Abbott Diabetes Care Inc. Sensitivity calibration of in vivo sensors used to measure analyte concentration
US8135548B2 (en) 2006-10-26 2012-03-13 Abbott Diabetes Care Inc. Method, system and computer program product for real-time detection of sensitivity decline in analyte sensors
CA2683962C (en) 2007-04-14 2017-06-06 Abbott Diabetes Care Inc. Method and apparatus for providing data processing and control in medical communication system
US8591410B2 (en) 2008-05-30 2013-11-26 Abbott Diabetes Care Inc. Method and apparatus for providing glycemic control
US8103456B2 (en) 2009-01-29 2012-01-24 Abbott Diabetes Care Inc. Method and device for early signal attenuation detection using blood glucose measurements
US10092229B2 (en) 2010-06-29 2018-10-09 Abbott Diabetes Care Inc. Calibration of analyte measurement system
US10136845B2 (en) 2011-02-28 2018-11-27 Abbott Diabetes Care Inc. Devices, systems, and methods associated with analyte monitoring devices and devices incorporating the same
EP4324399A3 (en) 2011-04-15 2024-05-15 DexCom, Inc. Advanced analyte sensor calibration and error detection
WO2013066849A1 (en) 2011-10-31 2013-05-10 Abbott Diabetes Care Inc. Model based variable risk false glucose threshold alarm prevention mechanism
US8710993B2 (en) 2011-11-23 2014-04-29 Abbott Diabetes Care Inc. Mitigating single point failure of devices in an analyte monitoring system and methods thereof
LT4056105T (lt) 2011-12-11 2024-01-10 Abbott Diabetes Care, Inc. Analitės jutiklių įrenginiai
WO2014035732A1 (en) 2012-08-30 2014-03-06 Abbot Diabetes Care Inc. Dropout detection in continuous analyte monitoring data during data excursions
EP2901153A4 (en) 2012-09-26 2016-04-27 Abbott Diabetes Care Inc METHOD AND DEVICE FOR IMPROVING DELAY CORRECTION FUNCTION DURING IN VIVO MEASUREMENT OF ANALYZ CONCENTRATION WITH ANALYZ CONCENTRATION VARIABILITY AND RANGE DATA
US10076285B2 (en) 2013-03-15 2018-09-18 Abbott Diabetes Care Inc. Sensor fault detection using analyte sensor data pattern comparison
US10433773B1 (en) 2013-03-15 2019-10-08 Abbott Diabetes Care Inc. Noise rejection methods and apparatus for sparsely sampled analyte sensor data
US9474475B1 (en) 2013-03-15 2016-10-25 Abbott Diabetes Care Inc. Multi-rate analyte sensor data collection with sample rate configurable signal processing
EP3089666B1 (en) 2013-12-31 2020-08-19 Abbott Diabetes Care Inc. Self-powered analyte sensor and devices using the same
EP4151150B1 (en) 2014-03-30 2025-08-27 Abbott Diabetes Care Inc. Method and apparatus for determining meal start and peak events in analyte monitoring systems
US9459089B2 (en) * 2014-04-09 2016-10-04 Qualcomm Incorporated Method, devices and systems for detecting an attachment of an electronic patch
CN105517491A (zh) * 2014-10-22 2016-04-20 深圳市光聚通讯技术开发有限公司 动态血糖监测系统及监测终端
CN108024765B (zh) 2015-07-10 2021-06-11 雅培糖尿病护理公司 对于生理参数进行动态葡萄糖曲线响应的系统、装置和方法
CN105193426B (zh) * 2015-11-05 2016-08-17 山东大数据医疗科技有限公司 无创式血糖仪
CN105496373A (zh) * 2016-01-02 2016-04-20 无锡桑尼安科技有限公司 智能化医疗辅助系统
CN113398380B (zh) 2016-09-27 2023-07-28 比格福特生物医药公司 药物注射和疾病管理系统、设备和方法
CA3037432A1 (en) 2016-12-12 2018-06-21 Bigfoot Biomedical, Inc. Alarms and alerts for medication delivery devices and related systems and methods
WO2018118822A1 (en) 2016-12-20 2018-06-28 Abbott Diabetes Care Inc. Systems, devices and methods for wireless communications in analyte monitoring devices
EP3570735A4 (en) 2017-01-23 2020-10-21 Abbott Diabetes Care Inc. SYSTEMS, DEVICES AND METHODS FOR INSERTING ANALYTE SENSOR
US11596330B2 (en) 2017-03-21 2023-03-07 Abbott Diabetes Care Inc. Methods, devices and system for providing diabetic condition diagnosis and therapy
US11331022B2 (en) 2017-10-24 2022-05-17 Dexcom, Inc. Pre-connected analyte sensors
DK3700416T3 (da) 2017-10-24 2024-09-30 Dexcom Inc På forhånd forbundne analytsensorer
US11464459B2 (en) 2017-12-12 2022-10-11 Bigfoot Biomedical, Inc. User interface for diabetes management systems including flash glucose monitor
US11116899B2 (en) * 2017-12-12 2021-09-14 Bigfoot Biomedical, Inc. User interface for diabetes management systems and devices
US10987464B2 (en) 2017-12-12 2021-04-27 Bigfoot Biomedical, Inc. Pen cap for insulin injection pens and associated methods and systems
US11077243B2 (en) * 2017-12-12 2021-08-03 Bigfoot Biomedical, Inc. Devices, systems, and methods for estimating active medication from injections
WO2019118531A2 (en) 2017-12-12 2019-06-20 Bigfoot Biomedical, Inc. Therapy assist information and/or tracking device and related methods and systems
US11083852B2 (en) * 2017-12-12 2021-08-10 Bigfoot Biomedical, Inc. Insulin injection assistance systems, methods, and devices
US11197964B2 (en) 2017-12-12 2021-12-14 Bigfoot Biomedical, Inc. Pen cap for medication injection pen having temperature sensor
USD911355S1 (en) 2018-03-29 2021-02-23 Bigfoot Biomedical, Inc. Display screen or portion thereof with graphical user interface
USD928199S1 (en) 2018-04-02 2021-08-17 Bigfoot Biomedical, Inc. Medication delivery device with icons
ES3026571T3 (en) 2018-06-07 2025-06-11 Abbott Diabetes Care Inc Analyte monitoring systems
US12205699B1 (en) 2018-10-30 2025-01-21 Bigfoot Biomedical, Inc. Method of pairing therapy devices using shared secrets, and related systems, methods and devices
CA3123936A1 (en) * 2019-01-04 2020-07-09 Abbott Diabetes Care Inc. Systems, devices, and methods for improved meal and therapy interfaces in analyte monitoring systems
US10998091B2 (en) * 2019-02-07 2021-05-04 Sandeep Patil Systems for monitoring compliance with a patch dosage regimen and methods of using the same
EP3928323A1 (en) * 2019-02-21 2021-12-29 Companion Medical, Inc. Methods, systems and devices for a medicament dose calculator
US11776684B2 (en) 2019-09-26 2023-10-03 Pacesetter, Inc Method and device for managing energy usage by a medical device
CN114901125A (zh) * 2019-11-15 2022-08-12 德克斯康公司 评估预测数据与相应的接收数据的差异的联合状态估计预测
AU2021333904A1 (en) 2020-08-31 2023-03-02 Abbott Diabetes Care Inc. Systems, devices, and methods for analyte sensor insertion

Family Cites Families (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5262035A (en) 1989-08-02 1993-11-16 E. Heller And Company Enzyme electrodes
US5264104A (en) 1989-08-02 1993-11-23 Gregg Brian A Enzyme electrodes
US5593852A (en) 1993-12-02 1997-01-14 Heller; Adam Subcutaneous glucose electrode
US5262305A (en) 1991-03-04 1993-11-16 E. Heller & Company Interferant eliminating biosensors
US5320715A (en) 1994-01-14 1994-06-14 Lloyd Berg Separation of 1-pentanol from cyclopentanol by extractive distillation
DE29711371U1 (de) 1997-06-30 1997-11-27 Siemens AG, 80333 München Vorrichtung zur Verbindung von Leiterplatten getrennter Geräte
US6175752B1 (en) 1998-04-30 2001-01-16 Therasense, Inc. Analyte monitoring device and methods of use
US8974386B2 (en) * 1998-04-30 2015-03-10 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US6036508A (en) 1998-12-21 2000-03-14 Hamilton Sundstrand Corporation Connector for interconnecting a bus bar to a circuit board
US7806886B2 (en) * 1999-06-03 2010-10-05 Medtronic Minimed, Inc. Apparatus and method for controlling insulin infusion with state variable feedback
WO2001088524A1 (en) 2000-05-12 2001-11-22 Therasense, Inc. Electrodes with multilayer membranes and methods of using and making the electrodes
WO2002015777A1 (en) * 2000-08-18 2002-02-28 Cygnus, Inc. Methods and devices for prediction of hypoglycemic events
US20030208113A1 (en) * 2001-07-18 2003-11-06 Mault James R Closed loop glycemic index system
US6544212B2 (en) * 2001-07-31 2003-04-08 Roche Diagnostics Corporation Diabetes management system
JP2003084101A (ja) 2001-09-17 2003-03-19 Dainippon Printing Co Ltd 光学素子用樹脂組成物、光学素子、およびプロジェクションスクリーン
US8010174B2 (en) * 2003-08-22 2011-08-30 Dexcom, Inc. Systems and methods for replacing signal artifacts in a glucose sensor data stream
US7299082B2 (en) 2003-10-31 2007-11-20 Abbott Diabetes Care, Inc. Method of calibrating an analyte-measurement device, and associated methods, devices and systems
EP2301428B1 (en) * 2003-12-09 2016-11-30 Dexcom, Inc. Signal processing for continuous analyte sensor
US7291107B2 (en) * 2004-08-26 2007-11-06 Roche Diagnostics Operations, Inc. Insulin bolus recommendation system
US7869851B2 (en) * 2004-12-23 2011-01-11 Roche Diagnostics Operations, Inc. System and method for determining insulin bolus quantities
US7547281B2 (en) * 2005-02-01 2009-06-16 Medtronic Minimed, Inc. Algorithm sensor augmented bolus estimator for semi-closed loop infusion system
KR100638727B1 (ko) 2005-02-28 2006-10-30 삼성전기주식회사 Ｚｉｇｂｅｅ 및 불루투스 겸용 송수신기
US8473022B2 (en) * 2008-01-31 2013-06-25 Abbott Diabetes Care Inc. Analyte sensor with time lag compensation
US7630748B2 (en) 2006-10-25 2009-12-08 Abbott Diabetes Care Inc. Method and system for providing analyte monitoring
US7946985B2 (en) * 2006-12-29 2011-05-24 Medtronic Minimed, Inc. Method and system for providing sensor redundancy
US20080228056A1 (en) * 2007-03-13 2008-09-18 Michael Blomquist Basal rate testing using frequent blood glucose input
EP2156346A1 (en) * 2007-05-03 2010-02-24 Novo Nordisk A/S Safety system for insulin delivery advisory algoritms
US10002233B2 (en) * 2007-05-14 2018-06-19 Abbott Diabetes Care Inc. Method and apparatus for providing data processing and control in a medical communication system
US8417311B2 (en) * 2008-09-12 2013-04-09 Optiscan Biomedical Corporation Fluid component analysis system and method for glucose monitoring and control
US7751907B2 (en) * 2007-05-24 2010-07-06 Smiths Medical Asd, Inc. Expert system for insulin pump therapy
US8444595B2 (en) * 2007-06-15 2013-05-21 Animas Corporation Methods to pair a medical device and at least a remote controller for such medical device
US20090143725A1 (en) * 2007-08-31 2009-06-04 Abbott Diabetes Care, Inc. Method of Optimizing Efficacy of Therapeutic Agent
EP4159114B1 (en) * 2007-10-09 2024-04-10 DexCom, Inc. Integrated insulin delivery system with continuous glucose sensor
US8377031B2 (en) * 2007-10-23 2013-02-19 Abbott Diabetes Care Inc. Closed loop control system with safety parameters and methods
US20090240127A1 (en) * 2008-03-20 2009-09-24 Lifescan, Inc. Methods of determining pre or post meal time slots or intervals in diabetes management
US8924159B2 (en) * 2008-05-30 2014-12-30 Abbott Diabetes Care Inc. Method and apparatus for providing glycemic control
US8734422B2 (en) * 2008-08-31 2014-05-27 Abbott Diabetes Care Inc. Closed loop control with improved alarm functions
JP6288903B2 (ja) * 2008-09-15 2018-03-07 デカ・プロダクツ・リミテッド・パートナーシップ 流体送達のためのシステムおよび方法
US20100198034A1 (en) 2009-02-03 2010-08-05 Abbott Diabetes Care Inc. Compact On-Body Physiological Monitoring Devices and Methods Thereof
US20100298685A1 (en) * 2009-05-22 2010-11-25 Abbott Diabetes Care Inc. Adaptive insulin delivery system
WO2011100624A1 (en) * 2010-02-11 2011-08-18 The Regents Of The University Of California Systems, devices and methods to deliver biological factors or drugs to a subject
US8579879B2 (en) * 2010-02-19 2013-11-12 Medtronic Minimed, Inc. Closed-loop glucose control startup

Also Published As

Publication number Publication date
AU2021266271B2 (en) 2024-01-11
EP2797660A1 (en) 2014-11-05
EP2797660A4 (en) 2015-08-19
AU2019201453B2 (en) 2021-08-12
AU2017228654A1 (en) 2017-10-05
AU2012362155A1 (en) 2014-01-23
EP2797660B1 (en) 2019-10-02
EP3662965A1 (en) 2020-06-10
EP4249034A3 (en) 2023-11-15
AU2024202384B2 (en) 2025-12-18
AU2021266271A1 (en) 2021-12-09
US20190192071A1 (en) 2019-06-27
EP3662965B1 (en) 2024-05-01
FI3662965T3 (fi) 2024-07-10
LT3662965T (lt) 2024-08-12
EP4249034A2 (en) 2023-09-27
US20130184547A1 (en) 2013-07-18
CA2840644A1 (en) 2013-07-04
ES2992389T3 (es) 2024-12-11
DK3662965T3 (da) 2024-07-22
AU2024202384A1 (en) 2024-05-02
WO2013102158A1 (en) 2013-07-04
AU2019201453A1 (en) 2019-03-21
JP2015505264A (ja) 2015-02-19

Similar Documents

Publication Publication Date Title
JP6479475B2 (ja) 薬剤投与量情報を決定するための方法及び装置
US12364419B2 (en) Mitigating single point failure of devices in an analyte monitoring system and methods thereof
US12254978B2 (en) Compatibility mechanisms for devices in a continuous analyte monitoring system and methods thereof
US12059272B2 (en) Method and device for analyzing continuously monitored physiological measurement values of a user
JP7598861B2 (ja) 分析物監視システムの食事および治療インタフェースを改善するためのシステム、デバイス、および方法
JP2016540229A (ja) データ管理ユニットおよびその動作方法
WO2014036175A1 (en) Modifying a sensitivity value to adjust for lag between in vivo sensor analyte values and an in vitro reference analyte value

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20151228

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20151228

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20160916

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20161115

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20170214

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20170808

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20171108

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20180109

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20180208

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20180717

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20181017

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20190109

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20190206

R150 Certificate of patent or registration of utility model

Ref document number: 6479475

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250